Results for the quarter ending 30th September 2025

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionRelated Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.5%Reaction day

₹205.70

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+4.9% vs market

Personal Care peers, median of 11sector+0.2%+4.3% vs sector

On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 4.3 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.5-0.4+4.9+0.2+4.3

Next day

-4.1-0.6-3.4+0.0-4.1

-4.1+0.3-4.4+0.6-4.7

-5.6+0.2-5.8+0.5-6.2

-5.4+0.1-5.6+1.1-6.5

-5.0+0.7-5.7+1.3-6.3

-5.2-0.3-4.9-0.2-5.0

15d

-13.0-2.0-11.0+0.3-13.3

-16.3-5.7-10.6-3.0-13.3

—-7.8—+1.0—

-3.6-4.6+1.0+2.6-6.2

UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Radix Industries reported Q2 FY26 revenue from operations of ₹1,209.27 lakhs, up about 50% YoY from ₹804.33 lakhs, though sequentially lower than Q1 FY26's ₹1,333.32 lakhs. Profit after tax for Q2 rose to ₹70.58 lakhs (vs ₹62.75 lakhs YoY) and H1 FY26 PAT jumped to ₹133.33 lakhs from ₹95.49 lakhs, a ~40% YoY increase. The company is debt-free with no borrowings and cash & equivalents surged to ₹1,542.85 lakhs (from ₹594.74 lakhs in March 2025) on strong operating cash flow of ₹946.83 lakhs in H1. Auditor Brahmayya & Co. issued an unqualified limited review report, and the company remains focused on its single segment of human hair processing.

Likely market impact

Healthy H1 profit growth, debt-free balance sheet, and sharply higher cash reserves are positives for shareholders; however, the sequential revenue dip in Q2 and rising other expenses (₹66.74 lakhs vs ₹44.97 lakhs in H1) suggest margin pressure worth monitoring.